Delivery Order SPE2DB22D1202-SPE2DB24FUQF2
Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XCOPRI 200 MG TABLET 30S medication. The contract has a potential value of $1,082.68 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563850465 - XCOPRI 100 MG TABLET 30S. The $1,242.66 contract has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is providing pharmaceutical products and medical supplies to support military treatment programs and facilities under this delivery order. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a $1,623.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 100 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,936.78 order is for 150mg tablet doses of the drug XCOPRI, to be delivered by December 28, 2023. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities under previous...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,623.99 worth of XCOPRI 100 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 200 MG TABLET 30S. The contract has a completion date of January 30, 2024, and a potential value of $1,701.81. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,794.10 to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a quantity of 30 tablets of the pharmaceutical drug XCOPRI 50 MG. The delivery order has a potential value of $1,082.66 and a completion date of February 15, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,219.60 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...